How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code QDQ: Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer. View classification details, related manufacturers, 510(k) clearances, and recall records.
A radiological computer assisted detection and diagnostic software for suspected lesions is an image processing device intended to aid in the detection, localization, and characterization of lesions suspicious for cancer on acquired medical images (e.g., mammography , MR, CT, ultrasound, radiography). The device detects, identifies and characterizes lesions suspicious for cancer based on features or information extracted from the images, and may provide information about the presence, location, and characteristics of the lesion to the user. Primary diagnostic and patient management decisions are made by the clinical user.Explore radiology records →
41 clearance records and 0 recall records in the covered releases, across 16 source company names and 1 product codes. Dated history runs from Nov 21, 2018 to Nov 6, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 1 | 0 |
| March 2026 | 1 | 0 |
| April 2026 | 2 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 2 | 0 |
| July 2026 | 1 | 0 |
| August 2026 | 2 | 0 |
| September 2026 | 1 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| QDQ · Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer | 41 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| CadAI-B DxK263749 · QDQ | BeamWorks, Inc. | 510(k) | Nov 6, 2026FDA decision date |
| qCT Lung (v1.0)K261517 · QDQ | Qure.Ai Technologies Pvt. , Ltd. | 510(k) | Sep 14, 2026FDA decision date |
| Transpara (2.1.0)K260898 · QDQ | Screenpoint Medical B.V. | 510(k) | Aug 14, 2026FDA decision date |
| CadAI-B DxK260086 · QDQ | BeamWorks, Inc. | 510(k) | Aug 12, 2026FDA decision date |
| See-Mode Augmented Reporting Tool, Breast (SMART-B)K260303 · QDQ | See-Mode Technologies Pty, Ltd. | 510(k) | Jul 28, 2026FDA decision date |
| MammoScreen® (5)K260714 · QDQ | Therapixel | 510(k) | Jun 26, 2026FDA decision date |
| Saige-DxK253825 · QDQ | DeepHealth, Inc. | 510(k) | Jun 15, 2026FDA decision date |
| DeepHealth ProstateAIK253682 · QDQ | Quantib B.V. | 510(k) | Apr 29, 2026FDA decision date |
| Lunit INSIGHT MMG (v1.1.10)K260320 · QDQ | Lunit, Inc. | 510(k) | Apr 23, 2026FDA decision date |
| Lunit INSIGHT DBT (V1.2)K253796 · QDQ | Lunit, Inc. | 510(k) | Mar 26, 2026FDA decision date |
| Median LCS (internal name) / eyonis LCS (trade name) (1.0)K251474 · QDQ | Median Technologies | 510(k) | Feb 6, 2026FDA decision date |
| Saige-DxK251873 · QDQ | DeepHealth, Inc. | 510(k) | Aug 11, 2025FDA decision date |
| Genius AI Detection 2.0K243341 · QDQ | Hologic, Inc. | 510(k) | Jul 31, 2025FDA decision date |
| MammoScreen® (4)K243679 · QDQ | Therapixel | 510(k) | Jul 3, 2025FDA decision date |
| QP-Prostate® CADK242683 · QDQ | Quibim S.L. | 510(k) | Mar 18, 2025FDA decision date |
| Prostate MR AI (VA10A)K241770 · QDQ | Siemens Healthcare GmbH | 510(k) | Mar 5, 2025FDA decision date |
| Saige-Dx (3.1.0)K243688 · QDQ | DeepHealth, Inc. | 510(k) | Dec 19, 2024FDA decision date |
| Transpara (2.1.0)K241831 · QDQ | Screenpoint Medical B.V. | 510(k) | Nov 25, 2024FDA decision date |
| Saige-DxK241747 · QDQ | DeepHealth, Inc. | 510(k) | Nov 18, 2024FDA decision date |
| ProFound Detection (V4.0)K240417 · QDQ | Icad, Inc. | 510(k) | Nov 8, 2024FDA decision date |
| Lunit INSIGHT DBT v1.1K242652 · QDQ | Lunit, Inc. | 510(k) | Oct 4, 2024FDA decision date |
| See-Mode Augmented Reporting Tool, Thyroid (SMART-T)K240697 · QDQ | See-Mode Technologies Pte, Ltd. | 510(k) | Sep 9, 2024FDA decision date |
| MammoScreen® (3)K240301 · QDQ | Therapixel | 510(k) | Aug 1, 2024FDA decision date |
| Lunit INSIGHT DBTK231470 · QDQ | Lunit, Inc. | 510(k) | Nov 6, 2023FDA decision date |
| Genius AI Detection 2.0 with CC-MLO CorrelationK230096 · QDQ | Hologic, Inc. | 510(k) | May 23, 2023FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.